Medical Device News Magazine

Thursday, June 8, 2023



Contact us 561.316.3330

Dr Azeem Latib, World-Renowned Interventional Cardiologist, to Join the Leadership Team of Supira Medical

Supira Medical, Inc., a Shifamed portfolio company, announced today that leading U.S. interventional cardiologist, Dr Azeem Latib, has joined the company as Medical Director to advance clinical activities and prepare the company for significant clinical and regulatory milestones.

Dr Azeem Latib played a key role throughout the development of Supira’s novel pVAD technology, previously serving as a clinical advisor and attending the initial first-in-human cases. Dr. Latib will retain his current position as the Section Head of Interventional Cardiology and Director of Structural Heart Interventions at Montefiore Health Systems in New York, NY.

“I am very excited to join the Supira team and believe it has an excellent offering with one system designed to support cardiovascular hemodynamics for both high-risk PCI (HRPCI) and cardiogenic shock (CS) patients,” stated Dr. Latib. “The unique pump is designed to achieve the required high continuous flow without the risk of bleeding often associated with these types of devices. This will advance clinical practice and enable more physicians to confidently perform these procedures.”

Dr. Latib’s professional expertise focuses on complex coronary interventions and structural heart disease, as well as a passion for new device innovation. He has authored over 700 peer-reviewed articles and serves on the editorial board for several publications including the Journal of American College of Cardiology (JACC), Cardiovascular Revascularization Medicine, EuroIntervention and Cardiac Interventions Today. Dr. Latib is a member of several professional organizations including the American College of Cardiology (ACC) and the European Society of Cardiology (ESC).

“Dr. Latib is an esteemed leader in the interventional space and his insights have been critical throughout our development process,” commented Dr. Nitin Salunke, President and CEO of Supira Medical. “We are thrilled to welcome him to Supira’s leadership team and look forward to his continued expertise as we build upon our successful first-in-human experience and accelerate our clinical activities.”

“We are grateful to have a physician of Dr. Latib’s caliber join the team as it speaks to the clinical importance of this technology,” stated Amr Salahieh, Founder of Shifamed and Chairman of Supira Medical’s Board. “His guidance will be critical as the company expands its clinical experience and prepares for the development of its pivotal study to support PMA approval.”

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

Mark Alley Appointed as President of Cipher Surgical Inc.

Mark Alley is a proven global executive leader with extensive experience building and developing teams that consistently exceed revenue goals.

Inspira Technologies Appoints Dr Adi Rizansky Nir, PhD as CMO

Dr Adi Rizansky Nir will play a critical role in overseeing and guiding Inspira's medical operations and strategic initiatives. With an unwavering commitment to patient care, innovation, and clinical excellence, the company states Dr. Nir is poised to make a transformative impact on the healthcare landscape within their organization and on the broader medical community.

Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer

In this newly established role, Wenlei Yang will drive, oversee and implement initiatives related to Olympus' new Diversity, Equity and Inclusion (DEI) directions set as part of the company's global ESG strategy announced on May 12, 2023. The company will deepen measures to fully realize the DEI principles in all facilities worldwide to foster a healthy organizational culture.

By using this website you agree to accept Medical Device News Magazine Privacy Policy